TRUST CO OF TOLEDO NA /OH/

Bank

Position in TRVI — Trevi Therapeutics, Inc.

CIK 1008937 HOLLAND, OH

Position in TRVI

as of Mar 31, 2026 · filed Apr 15, 2026 Compact

Position Value

$1,568,818

+$1,111,813 QoQ

Shares Held

131,502

+260.3% QoQ

Ownership

0.093%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 27.757752733798725.ToString("F0")% Shared 0.ToString("F0")% None 72.24224726620128.ToString("F0")%

Healthcare · as of Mar 31, 2026

TRUST CO OF TOLEDO NA /OH/ holds $1,850,012 across 14 Biotechnology names. TRVI ranks #1 (84.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TRVI	Trevi Therapeutics, Inc. This page	131,502	$1,568,818
2	LCTX	Lineage Cell Therapeutics, Inc.	83,795	$132,396
3	VRTX	Vertex Pharmaceuticals Inc / Ma	245	$109,402
4	CRDF	Cardiff Oncology, Inc.	9,000	$14,580
5	ATYR	aTYR PHARMA INC	16,640	$12,979
6	REGN	Regeneron Pharmaceuticals, Inc.	8	$6,181
7	CRMD	CorMedix Inc.	360	$2,444
8	EDIT	Editas Medicine, Inc.	500	$1,235

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,568,818	131,502	+260.3%	Shares	Sole	2026-04-15
2025-12-31	$457,005	36,502	0.0%	Shares	Sole	2026-01-20
2025-09-30	$333,993	36,502	0.0%	Shares	Sole	2025-10-16
2025-06-30	$199,665	36,502	0.0%	Shares	Sole	2025-07-24
2025-03-31	$229,597	36,502	0.0%	Shares	Sole	2025-04-17
2024-12-31	$150,388	36,502	0.0%	Shares	Sole	2025-01-13
2024-09-30	$121,916	36,502	0.0%	Shares	Sole	2024-10-02
2024-06-30	$108,775	36,502	0.0%	Shares	Sole	2024-07-08
2024-03-31	$125,931	36,502	0.0%	Shares	Sole	2024-04-04
2023-12-31	$48,912	36,502	-68.8%	Shares	Sole	2024-01-04
2023-09-30	$255,376	117,145	-6.2%	Shares	Sole	2023-10-19
2023-06-30	$298,408	124,857	+50.4%	Shares	Sole	2023-07-10
2023-03-31	$153,550	83,000	—	Shares	Sole	2023-04-04
No filing history on record for this holder in this stock.